2022 Q4 Form 10-Q Financial Statement

#000190359622000849 Filed on November 21, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $128.6K $173.0K $214.1K
YoY Change -35.6% -19.19% -22.16%
Cost Of Revenue $42.74K $59.77K $62.25K
YoY Change -21.65% -3.98% -41.2%
Gross Profit $85.82K $113.2K $151.8K
YoY Change -40.85% -25.43% -10.25%
Gross Profit Margin 66.75% 65.44% 70.92%
Selling, General & Admin $928.9K $383.1K $638.7K
YoY Change 101.34% -40.02% -31.95%
% of Gross Profit 1082.43% 338.4% 420.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.100K $4.230K $29.98K
YoY Change -85.77% -85.89% -45.12%
% of Gross Profit 4.78% 3.74% 19.75%
Operating Expenses $928.9K $383.1K $638.7K
YoY Change 101.35% -40.02% -31.95%
Operating Profit -$843.1K -$269.9K -$486.9K
YoY Change 166.57% -44.57% -36.72%
Interest Expense $2.591M -$7.160M $4.348M
YoY Change -10.36% -264.66% -134.39%
% of Operating Profit
Other Income/Expense, Net -$7.143M $0.00
YoY Change
Pretax Income $1.748M -$7.413M $3.934M
YoY Change -34.04% -288.44% -129.33%
Income Tax $16.51K $22.54K
% Of Pretax Income 0.94%
Net Earnings $1.809M -$7.415M $3.952M
YoY Change -14.52% -287.63% -129.49%
Net Earnings / Revenue 1406.81% -4286.86% 1846.2%
Basic Earnings Per Share
Diluted Earnings Per Share $0.11 -$503.6K $55.45K
COMMON SHARES
Basic Shares Outstanding 14.72M shares 14.72M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.33K $40.41K $56.27K
YoY Change -96.76% -28.19% -6.42%
Cash & Equivalents $18.33K $40.41K $56.27K
Short-Term Investments
Other Short-Term Assets $28.16K $13.97K $12.40K
YoY Change 101.57% 12.66% 47.09%
Inventory $11.99K $28.71K $35.84K
Prepaid Expenses $28.16K $13.97K
Receivables
Other Receivables
Total Short-Term Assets $58.48K $83.09K $104.5K
YoY Change -90.74% -20.49% -15.01%
LONG-TERM ASSETS
Property, Plant & Equipment $552.8K $556.9K $2.011M
YoY Change -3.82% -72.31% -16.01%
Goodwill $22.19K
YoY Change
Intangibles
YoY Change
Long-Term Investments $22.19K $22.15K $0.00
YoY Change -11.31%
Other Assets $27.18K $91.71K $83.34K
YoY Change -66.92% 10.04% 202.83%
Total Long-Term Assets $784.8K $878.4K $2.094M
YoY Change -16.31% -58.05% -13.52%
TOTAL ASSETS
Total Short-Term Assets $58.48K $83.09K $104.5K
Total Long-Term Assets $784.8K $878.4K $2.094M
Total Assets $843.2K $961.5K $2.199M
YoY Change -46.26% -56.27% -13.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.235M $148.4K $2.241M
YoY Change 16.46% -93.38% 54.96%
Accrued Expenses $1.853M $1.685M $1.122M
YoY Change 50.3% 50.18% 90.14%
Deferred Revenue
YoY Change
Short-Term Debt $9.310K $9.310K $464.3K
YoY Change 0.0% -97.99% 4887.22%
Long-Term Debt Due $240.3K $93.34K $125.0K
YoY Change 861.16% -25.33% -64.7%
Total Short-Term Liabilities $10.42M $12.88M $12.05M
YoY Change 28.78% 6.83% -49.36%
LONG-TERM LIABILITIES
Long-Term Debt $7.429M $7.320M $6.774M
YoY Change 3.4% 8.05% 2.47%
Other Long-Term Liabilities $600.1K $635.9K $202.7K
YoY Change -14.6% 213.67% -35.0%
Total Long-Term Liabilities $8.029M $7.956M $6.977M
YoY Change 1.8% 14.03% 0.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.42M $12.88M $12.05M
Total Long-Term Liabilities $8.029M $7.956M $6.977M
Total Liabilities $18.45M $20.83M $17.42M
YoY Change 15.46% 19.57% -40.59%
SHAREHOLDERS EQUITY
Retained Earnings -$38.07M -$39.88M
YoY Change 10.37%
Common Stock $22.17K $14.72K
YoY Change 50.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.62M -$17.96M -$15.23M
YoY Change
Total Liabilities & Shareholders Equity $843.2K $961.5K $2.199M
YoY Change -46.26% -56.27% -13.59%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $1.809M -$7.415M $3.952M
YoY Change -14.52% -287.63% -129.49%
Depreciation, Depletion And Amortization $4.100K $4.230K $29.98K
YoY Change -85.77% -85.89% -45.12%
Cash From Operating Activities -$235.9K -$173.4K -$176.1K
YoY Change -54.36% -1.56% 94.87%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $17.18K $14.46K
YoY Change -100.0% 18.81%
Cash From Investing Activities $0.00 $17.18K $14.46K
YoY Change -100.0% 18.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 220.0K 150.0K 150.6K
YoY Change -194.47% -0.4% 58.53%
NET CHANGE
Cash From Operating Activities -235.9K -173.4K -176.1K
Cash From Investing Activities 0.000 17.18K 14.46K
Cash From Financing Activities 220.0K 150.0K 150.6K
Net Change In Cash -15.90K -6.200K -11.06K
YoY Change -103.12% -43.94% -339.39%
FREE CASH FLOW
Cash From Operating Activities -$235.9K -$173.4K -$176.1K
Capital Expenditures $0.00
Free Cash Flow -$235.9K
YoY Change -53.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2022Q3 kays Gain Loss On Settlement
GainLossOnSettlement
usd
kays Gain Loss On Settlement
GainLossOnSettlement
usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 kays Diluted Net Income Loss Per Common Share
DilutedNetIncomeLossPerCommonShare
CY2021 kays Share Cancellation
ShareCancellation
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
kays Tax Liabilities
TaxLiabilities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 kays Exchange Of Pre Of Preferred Shares Series C To Series D
ExchangeOfPreOfPreferredSharesSeriesCToSeriesD
usd
kays Loss Gain On Impairment Of Rightofuse Asset
LossGainOnImpairmentOfRightofuseAsset
usd
us-gaap Derivative Cost Of Hedge
DerivativeCostOfHedge
usd
kays Gain On Settlement
GainOnSettlement
usd
kays Adoption Of Lease Standard Asc842
AdoptionOfLeaseStandardAsc842
usd
kays Reclassification Of Derivative Liabilities To Additional Paid In Capital
ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital
usd
kays Value Of Common Shares Issued For Conversion Of Principle And Interest
ValueOfCommonSharesIssuedForConversionOfPrincipleAndInterest
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001530746
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 kays Notes Payable Non Current
NotesPayableNonCurrent
usd
CY2021Q4 kays Notes Payable Non Current
NotesPayableNonCurrent
usd
kays Capitalization Of Interest Pursuant To Amended Agreement
CapitalizationOfInterestPursuantToAmendedAgreement
usd
kays Shares Issued For Cash From Stock Payable
SharesIssuedForCashFromStockPayable
usd
kays Settlment Of Accounts Payable With Note Payable
SettlmentOfAccountsPayableWithNotePayable
usd
kays Settlement Of Related Party Liabilities In Excess Of Net Book Value Of Asset Distributed
SettlementOfRelatedPartyLiabilitiesInExcessOfNetBookValueOfAssetDistributed
usd
CY2022Q3 kays Structural
Structural
usd
CY2021Q4 kays Structural
Structural
usd
CY2021Q4 us-gaap Other Receivables
OtherReceivables
usd
kays Conversion Of Debtreclas To Apic
ConversionOfDebtreclasToApic
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2022Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
usd
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
usd
CY2022Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
dei Entity File Number
EntityFileNumber
333-177532
dei Entity Registrant Name
EntityRegistrantName
KAYA HOLDINGS, INC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0898007
dei Entity Address Address Line1
EntityAddressAddressLine1
915 Middle River Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 316
dei Entity Address City Or Town
EntityAddressCityOrTown
Ft. Lauderdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33304
dei City Area Code
CityAreaCode
954
dei Local Phone Number
LocalPhoneNumber
892-6911
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14722835 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40408 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
565979 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
28714 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
51484 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13967 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13967 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
83089 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
631430 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
207680 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
255770 usd
CY2022Q3 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
368230 usd
CY2021Q4 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
364331 usd
CY2022Q3 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
556897 usd
CY2021Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
574733 usd
CY2022Q3 kays Investment In Subsidaries
InvestmentInSubsidaries
22150 usd
CY2021Q4 kays Investment In Subsidaries
InvestmentInSubsidaries
25021 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
91706 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82159 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
878433 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
937683 usd
CY2022Q3 us-gaap Assets
Assets
961522 usd
CY2021Q4 us-gaap Assets
Assets
1569113 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
971420 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
918148 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Fair Value Disclosure
AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
263933 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Fair Value Disclosure
AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
141990 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
1602273 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1152783 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
82908 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
79875 usd
CY2022Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
859505 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
782107 usd
CY2022Q3 kays Convertible Notes Payable Related Party Net Of Discount
ConvertibleNotesPayableRelatedPartyNetOfDiscount
81660 usd
CY2021Q4 kays Convertible Notes Payable Related Party Net Of Discount
ConvertibleNotesPayableRelatedPartyNetOfDiscount
0 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
93340 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
25000 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
9312 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
9312 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8995335 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4980563 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
12878026 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8089778 usd
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
250000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
250000 usd
CY2022Q3 kays Convertible Notes Payable Long Term Net Of Discount
ConvertibleNotesPayableLongTermNetOfDiscount
342290 usd
CY2021Q4 kays Convertible Notes Payable Long Term Net Of Discount
ConvertibleNotesPayableLongTermNetOfDiscount
477634 usd
CY2022Q3 kays Convertible Notes Payable Non Current
ConvertibleNotesPayableNonCurrent
7069862 usd
CY2021Q4 kays Convertible Notes Payable Non Current
ConvertibleNotesPayableNonCurrent
6934518 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
500000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
500000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
135881 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
202722 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7955743 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7887240 usd
CY2022Q3 us-gaap Liabilities
Liabilities
20833769 usd
CY2021Q4 us-gaap Liabilities
Liabilities
15977018 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14722835 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14722835 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14722835 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14722835 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
14723 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
14723 usd
CY2022Q3 us-gaap Preferred Stock Shares Subscribed But Unissued Value
PreferredStockSharesSubscribedButUnissuedValue
163630 usd
CY2021Q4 us-gaap Preferred Stock Shares Subscribed But Unissued Value
PreferredStockSharesSubscribedButUnissuedValue
163630 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21752066 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21735185 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39880555 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34495346 usd
CY2022Q3 kays Accumulated Other Comprehensive Income
AccumulatedOtherComprehensiveIncome
-12900 usd
CY2021Q4 kays Accumulated Other Comprehensive Income
AccumulatedOtherComprehensiveIncome
-3719 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-17963036 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-12585527 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
-1909211 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-1822378 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-19872247 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-14407905 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
961522 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1569113 usd
CY2022Q3 us-gaap Revenues
Revenues
172968 usd
CY2021Q3 us-gaap Revenues
Revenues
214051 usd
us-gaap Revenues
Revenues
556818 usd
us-gaap Revenues
Revenues
690267 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
59771 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
62245 usd
us-gaap Cost Of Revenue
CostOfRevenue
182369 usd
us-gaap Cost Of Revenue
CostOfRevenue
224788 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
113197 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
151806 usd
us-gaap Gross Profit
GrossProfit
374449 usd
us-gaap Gross Profit
GrossProfit
465479 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
182140 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
316979 usd
us-gaap Professional Fees
ProfessionalFees
565529 usd
us-gaap Professional Fees
ProfessionalFees
682884 usd
CY2022Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
94176 usd
CY2021Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
96436 usd
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
296327 usd
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
271057 usd
CY2021Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
-13696 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
-58626 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
106745 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
225245 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
380920 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
625093 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
383061 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
624964 usd
us-gaap Operating Expenses
OperatingExpenses
1242776 usd
us-gaap Operating Expenses
OperatingExpenses
1520408 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-269864 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-473158 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-868327 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1054929 usd
CY2022Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
158880 usd
CY2021Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
153746 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
466319 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
464566 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6613 usd
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
60113 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
163817 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
273184 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-566080 usd
CY2021Q3 kays Gain Loss On Settlement
GainLossOnSettlement
-45458 usd
kays Gain Loss On Settlement
GainLossOnSettlement
-45458 usd
CY2022Q3 kays Gain Loss On Disposal
GainLossOnDisposal
-17177 usd
CY2021Q3 kays Gain Loss On Disposal
GainLossOnDisposal
-13214 usd
kays Gain Loss On Disposal
GainLossOnDisposal
-17177 usd
kays Gain Loss On Disposal
GainLossOnDisposal
-13214 usd
CY2022Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Other Comprehensive Income Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
-6994461 usd
CY2021Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Other Comprehensive Income Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
4562135 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Other Comprehensive Income Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
-3904639 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Other Comprehensive Income Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
9825029 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7142777 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4406948 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4517598 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8579871 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7412641 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3933790 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-5385925 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
7524942 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22535 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
77398 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-7435176 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
3933790 usd
us-gaap Profit Loss
ProfitLoss
-5463323 usd
us-gaap Profit Loss
ProfitLoss
7524942 usd
CY2022Q3 us-gaap Net Income Loss From Real Estate Investment Partnership Attributable To Noncontrolling Interest
NetIncomeLossFromRealEstateInvestmentPartnershipAttributableToNoncontrollingInterest
-20279 usd
CY2021Q3 us-gaap Net Income Loss From Real Estate Investment Partnership Attributable To Noncontrolling Interest
NetIncomeLossFromRealEstateInvestmentPartnershipAttributableToNoncontrollingInterest
-18003 usd
us-gaap Net Income Loss From Real Estate Investment Partnership Attributable To Noncontrolling Interest
NetIncomeLossFromRealEstateInvestmentPartnershipAttributableToNoncontrollingInterest
-78114 usd
us-gaap Net Income Loss From Real Estate Investment Partnership Attributable To Noncontrolling Interest
NetIncomeLossFromRealEstateInvestmentPartnershipAttributableToNoncontrollingInterest
-83456 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7414897 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3951793 usd
us-gaap Net Income Loss
NetIncomeLoss
-5385209 usd
us-gaap Net Income Loss
NetIncomeLoss
7608398 usd
CY2022Q3 kays Basic Net Loss Per Common Share
BasicNetLossPerCommonShare
-0.50
CY2021Q3 kays Basic Net Loss Per Common Share
BasicNetLossPerCommonShare
0.26
kays Basic Net Loss Per Common Share
BasicNetLossPerCommonShare
-0.37
kays Basic Net Loss Per Common Share
BasicNetLossPerCommonShare
0.52
CY2022Q3 kays Weighted Average Number Of Common Shares Outstanding Basic
WeightedAverageNumberOfCommonSharesOutstandingBasic
14722835 shares
CY2021Q3 kays Weighted Average Number Of Common Shares Outstanding Basic
WeightedAverageNumberOfCommonSharesOutstandingBasic
15007329 shares
kays Weighted Average Number Of Common Shares Outstanding Basic
WeightedAverageNumberOfCommonSharesOutstandingBasic
14722835 shares
kays Weighted Average Number Of Common Shares Outstanding Basic
WeightedAverageNumberOfCommonSharesOutstandingBasic
14771003 shares
CY2022Q3 kays Diluted Net Income Loss Per Common Share
DilutedNetIncomeLossPerCommonShare
0.00
kays Diluted Net Income Loss Per Common Share
DilutedNetIncomeLossPerCommonShare
-0.37
kays Diluted Net Income Loss Per Common Share
DilutedNetIncomeLossPerCommonShare
0.11
CY2022Q3 kays Weighted Average Number Of Common Shares Outstanding Diluted
WeightedAverageNumberOfCommonSharesOutstandingDiluted
14722835 shares
CY2021Q3 kays Weighted Average Number Of Common Shares Outstanding Diluted
WeightedAverageNumberOfCommonSharesOutstandingDiluted
71263410 shares
kays Weighted Average Number Of Common Shares Outstanding Diluted
WeightedAverageNumberOfCommonSharesOutstandingDiluted
14722835 shares
kays Weighted Average Number Of Common Shares Outstanding Diluted
WeightedAverageNumberOfCommonSharesOutstandingDiluted
71027084 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7414897 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3951793 usd
us-gaap Net Income Loss
NetIncomeLoss
-5385209 usd
us-gaap Net Income Loss
NetIncomeLoss
7608398 usd
CY2022Q3 kays Foreign Currency Adjustments
ForeignCurrencyAdjustments
-6162 usd
CY2021Q3 kays Foreign Currency Adjustments
ForeignCurrencyAdjustments
1347 usd
kays Foreign Currency Adjustments
ForeignCurrencyAdjustments
-17900 usd
kays Foreign Currency Adjustments
ForeignCurrencyAdjustments
2966 usd
CY2022Q3 kays Comprehensive Income Loss
ComprehensiveIncomeLoss
-7421059 usd
CY2021Q3 kays Comprehensive Income Loss
ComprehensiveIncomeLoss
3950446 usd
kays Comprehensive Income Loss
ComprehensiveIncomeLoss
-5403109 usd
kays Comprehensive Income Loss
ComprehensiveIncomeLoss
7605432 usd
CY2022Q3 kays Net Loss Attirbuted To Noncontrolling Interest
NetLossAttirbutedToNoncontrollingInterest
-20279 usd
CY2021Q3 kays Net Loss Attirbuted To Noncontrolling Interest
NetLossAttirbutedToNoncontrollingInterest
18003 usd
kays Net Loss Attirbuted To Noncontrolling Interest
NetLossAttirbutedToNoncontrollingInterest
78114 usd
kays Net Loss Attirbuted To Noncontrolling Interest
NetLossAttirbutedToNoncontrollingInterest
83456 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7400780 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3968449 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-5324995 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7688888 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-24926089 usd
CY2021 kays Imputed Interest
ImputedInterest
22438 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
35000 usd
CY2021 kays Common Stock Issued For Notes Conversion And Interest
CommonStockIssuedForNotesConversionAndInterest
196015 usd
CY2021 kays Settlement Of Related Party Accrued Compensation
SettlementOfRelatedPartyAccruedCompensation
559058 usd
CY2021 kays Reclassification Of Derivative Liabilities To Additional Paid In Capital
ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital
283326 usd
CY2021 kays Business Combination Of Foreign Entities
BusinessCombinationOfForeignEntities
35805 usd
CY2021 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-6711 usd
CY2021 us-gaap Profit Loss
ProfitLoss
9393253 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-14407905 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-14407905 usd
kays Imputed Interest
ImputedInterest
16829 usd
kays Settlement Of Related Party Accrued Compensation
SettlementOfRelatedPartyAccruedCompensation
52 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-17900 usd
us-gaap Profit Loss
ProfitLoss
-5463323 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-19872247 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5385209 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7608398 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-78114 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-83456 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
17836 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
90221 usd
kays Imputed Interests
ImputedInterests
16829 usd
kays Imputed Interests
ImputedInterests
16767 usd
kays Loss Gain On Disposal Of Fixed Assets
LossGainOnDisposalOfFixedAssets
-17177 usd
kays Loss Gain On Disposal Of Fixed Assets
LossGainOnDisposalOfFixedAssets
-13214 usd
kays Loss Gain On Impairment Of Rightofuse Asset
LossGainOnImpairmentOfRightofuseAsset
-58626 usd
us-gaap Derivative Cost Of Hedge
DerivativeCostOfHedge
566080 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-3904639 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
9825029 usd
kays Gain On Settlement
GainOnSettlement
-45458 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
163817 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
273184 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
263 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-22770 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-11778 usd
kays Rightofuse Asset1
RightofuseAsset1
-71828 usd
kays Rightofuse Asset1
RightofuseAsset1
-44122 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
14679 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
35142 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
449490 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
447799 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
53272 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
175526 usd
kays Accounts Payable And Accrued Expenses Related Parties
AccountsPayableAndAccruedExpensesRelatedParties
121995 usd
kays Accounts Payable And Accrued Expenses Related Parties
AccountsPayableAndAccruedExpensesRelatedParties
345082 usd
kays Rightofuse Liabilities1
RightofuseLiabilities1
87546 usd
kays Rightofuse Liabilities1
RightofuseLiabilities1
-44432 usd
kays Tax Liabilities
TaxLiabilities
-77398 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-682851 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-526663 usd
kays Proceeds From Sales Of Fixed Assets
ProceedsFromSalesOfFixedAssets
17177 usd
kays Proceeds From Sales Of Fixed Assets
ProceedsFromSalesOfFixedAssets
14460 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17177 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14460 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
35000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
150000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
466000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
27273 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
150000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
528273 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-515674 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
16070 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-9897 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2966 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
565979 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43162 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40408 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56266 usd
kays Adoption Of Lease Standard Asc842
AdoptionOfLeaseStandardAsc842
23738 usd
kays Reclassification Of Derivative Liabilities To Additional Paid In Capital
ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital
283326 usd
kays Derivative Liability On Convertible Note Payable
DerivativeLiabilityOnConvertibleNotePayable
110133 usd
kays Derivative Liability On Convertible Note Payable
DerivativeLiabilityOnConvertibleNotePayable
316000 usd
kays Value Of Common Shares Issued For Conversion Of Principle And Interest
ValueOfCommonSharesIssuedForConversionOfPrincipleAndInterest
196015 usd
kays Capitalization Of Interest Pursuant To Amended Agreement
CapitalizationOfInterestPursuantToAmendedAgreement
18992 usd
kays Shares Issued For Cash From Stock Payable
SharesIssuedForCashFromStockPayable
250 usd
kays Settlment Of Accounts Payable With Note Payable
SettlmentOfAccountsPayableWithNotePayable
55000 usd
kays Settlement Of Related Party Liabilities In Excess Of Net Book Value Of Asset Distributed
SettlementOfRelatedPartyLiabilitiesInExcessOfNetBookValueOfAssetDistributed
12453 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
5385209 usd
CY2021 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
7608398 usd
CY2022Q3 kays Working Capital Deficiency
WorkingCapitalDeficiency
12794397 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zRmP1gQ2zCPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_z7MMlQeBqMQh">Reclassifications</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified to conform to the current period presentation.</span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zVSUjqShAbi7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z7IU02K9yGel">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such estimates and assumptions impact both assets and liabilities, including but not limited to: net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, the valuation of intangible assets, estimate of fair value of share based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount, estimates of tax liabilities and estimates of the probability and potential magnitude of contingent liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future non-conforming events. Accordingly, actual results could differ significantly from estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_znQtFCBi2FPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zT3WHmqXxvRe">Risks and Uncertainties</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s operations are subject to risk and uncertainties including financial, operational, regulatory and other risks including the potential risk of business failure.  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has experienced, and in the future expects to continue to experience, variability in its sales and earnings.  The factors expected to contribute to this variability include, among others, (i) the uncertainty associated with the commercialization and ultimate success of the product, (ii) competition inherent at other locations where product is expected to be sold (iii) general economic conditions and (iv) the related volatility of prices pertaining to the cost of sales. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">     </span></p>
us-gaap Fiscal Period
FiscalPeriod
<p id="xdx_84A_eus-gaap--FiscalPeriod_zCwzAHzgz1y2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zugYSIi6uTb1">Fiscal Year</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s fiscal year-end is December 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
42965 usd
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
42965 usd
CY2022Q3 kays Hvac
Hvac
44430 usd
CY2021Q4 kays Hvac
Hvac
44430 usd
CY2022Q3 us-gaap Land
Land
533778 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
28714 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
51484 usd
CY2022Q3 us-gaap Inventory Finished Homes
InventoryFinishedHomes
0 usd
CY2021Q4 us-gaap Inventory Finished Homes
InventoryFinishedHomes
0 usd
us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p id="xdx_847_eus-gaap--DerivativesReportingOfDerivativeActivity_zpn8WWUWLsm8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zPVdNDhEZEU6">Derivative Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of it financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. For option-based simple derivative financial instruments, the Company uses the Binomial option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2017, the FASB issued ASU 2017-11 <i>Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivative and Hedging (Topic 815).</i> The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. The amendment also clarifies existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (“EPS”) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt-Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception. Those amendments do not have an accounting effect.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to this Update, an equity-linked financial instrument with a down round feature that otherwise is not required to be classified as a liability under the guidance in Topic 480 is evaluated under the guidance in Topic 815, Derivatives and Hedging, to determine whether it meets the definition of a derivative. If it meets that definition, the instrument (or embedded feature) is evaluated to determine whether it is indexed to an entity’s own stock as part of the analysis of whether it qualifies for a scope exception from derivative accounting. Generally, for warrants and conversion options embedded in financial instruments that are deemed to have a debt host (assuming the underlying shares are readily convertible to cash or the contract provides for net settlement such that the embedded conversion option meets the definition of a derivative), the existence of a down round feature results in an instrument not being considered indexed to an entity’s own stock. This results in a reporting entity being required to classify the freestanding financial instrument or the bifurcated conversion option as a liability, which the entity must measure at fair value initially and at each subsequent reporting date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amendments in this Update revise the guidance for instruments with down round features in Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, which is considered in determining whether an equity-linked financial instrument qualifies for a scope exception from derivative accounting. An entity still is required to determine whether instruments would be classified in equity under the guidance in Subtopic 815-40 in determining whether they qualify for that scope exception. If they do qualify, freestanding instruments with down round features are no longer classified as liabilities and embedded conversion options with down round features are no longer bifurcated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For entities that present EPS in accordance with Topic 260, and when the down round feature is included in an equity-classified freestanding financial instrument, the value of the effect of the down round feature is treated as a dividend when it is triggered and as a numerator adjustment in the basic EPS calculation. This reflects the occurrence of an economic transfer of value to the holder of the instrument, while alleviating the complexity and income statement volatility associated with fair value measurement on an ongoing basis. Convertible instruments are unaffected by the Topic 260 amendments in this Update.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amendments in Part 1 of this Update are a cost savings relative to former accounting. This is because, assuming the required criteria for equity classification in Subtopic 815-40 are met, an entity that issued such an instrument no longer measures the instrument at fair value at each reporting period (in the case of warrants) or separately accounts for a bifurcated derivative (in the case of convertible instruments) on the basis of the existence of a down round feature. For convertible instruments with embedded conversion options that have down round features, applying specialized guidance such as the model for contingent beneficial conversion features rather than bifurcating an embedded derivative also reduces cost and complexity. Under that specialized guidance, the issuer recognizes the intrinsic value of the feature only when the feature becomes beneficial instead of bifurcating the conversion option and measuring it at fair value each reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amendments in Part II of this Update replace the indefinite deferral of certain guidance in Topic 480 with a scope exception. This has the benefit of improving the readability of the Codification and reducing the complexity associated with navigating the guidance in Topic 480.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted this new standard on January 1, 2019; however, the Company needs to continue the derivative liabilities due to variable conversion price on some of the convertible instruments. As such, it did not have a material impact on the Company’s consolidated financial statements. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
us-gaap Revenue Recognition Leases Operating
RevenueRecognitionLeasesOperating
<p id="xdx_84E_eus-gaap--RevenueRecognitionLeasesOperating_zDmgvH47S185" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zo1ev3ZMUTld">Operating Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We lease our retail stores under non-cancellable operating leases. Most store leases include tenant allowances from landlords, rent escalation clauses and/or contingent rent provisions. We recognize rent expense on a straight-line basis over the lease term, excluding contingent rent, and record the difference between the amount charged to expense and the rent paid as a deferred rent liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and operating lease liabilities in our consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses an incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The lease payments used to determine the Company's operating lease asset may include lease incentives and stated rent increases. Our lease term may include the option to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
782107 usd
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 kays Atm Machine1
AtmMachine1
5600 usd
CY2021Q4 kays Atm Machine1
AtmMachine1
5600 usd
CY2022Q3 kays Computer1
Computer1
30713 usd
CY2021Q4 kays Computer1
Computer1
30713 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
925127 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
939064 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
-368230 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
364331 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
556897 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
574733 usd
us-gaap Depreciation
Depreciation
17836 usd
CY2021Q4 us-gaap Land
Land
533778 usd
CY2022Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
147636 usd
CY2021Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
147636 usd
CY2022Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
69312 usd
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
69312 usd
CY2022Q3 kays Sign
Sign
12758 usd
CY2021Q4 kays Sign
Sign
12758 usd
CY2022Q3 kays Vehicle
Vehicle
37936 usd
CY2021Q4 kays Vehicle
Vehicle
51872 usd
us-gaap Depreciation
Depreciation
92715 usd
CY2020Q4 us-gaap Assets Net
AssetsNet
173658 usd
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
173658 usd
CY2022Q3 us-gaap Other Receivables
OtherReceivables
9801 usd
CY2022Q3 kays Rent Deposits
RentDeposits
11016 usd
CY2021Q4 kays Rent Deposits
RentDeposits
11016 usd
CY2022Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
70889 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
71143 usd
CY2022Q3 us-gaap Noncurrent Assets
NoncurrentAssets
91706 usd
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
82159 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8995335 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4980563 usd
CY2022Q3 kays Total Convertible Debt
TotalConvertibleDebt
7587152 usd
CY2021Q4 kays Total Convertible Debt
TotalConvertibleDebt
7437152 usd
CY2022Q3 kays Convertible Notes Payable Long Term Net Of Discounts
ConvertibleNotesPayableLongTermNetOfDiscounts
-423950 usd
CY2021Q4 kays Convertible Notes Payable Long Term Net Of Discounts
ConvertibleNotesPayableLongTermNetOfDiscounts
-477634 usd
CY2022Q3 kays Convertible Notes Payable Net Of Discount
ConvertibleNotesPayableNetOfDiscount
7163202 usd
CY2021Q4 kays Convertible Notes Payable Net Of Discount
ConvertibleNotesPayableNetOfDiscount
6959518 usd
CY2022Q3 kays Convertible Debt Net Of Discounts Current
ConvertibleDebtNetOfDiscountsCurrent
93340 usd
CY2021Q4 kays Convertible Debt Net Of Discounts Current
ConvertibleDebtNetOfDiscountsCurrent
25000 usd
CY2022Q3 us-gaap Convertible Debt
ConvertibleDebt
7069862 usd
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
6934518 usd
kays Initial Derivative Liabilities
InitialDerivativeLiabilities
110134 usd
CY2021 kays Initial Derivative Liabilities
InitialDerivativeLiabilities
882080 usd
kays Derivative Liability Expense
DerivativeLiabilityExpense
0 usd
CY2022Q3 us-gaap Due To Other Related Parties Noncurrent
DueToOtherRelatedPartiesNoncurrent
9312 usd
CY2021Q4 us-gaap Due To Other Related Parties Noncurrent
DueToOtherRelatedPartiesNoncurrent
9312 usd
CY2022Q3 us-gaap Loans Payable
LoansPayable
250000 usd
CY2021Q4 us-gaap Loans Payable
LoansPayable
250000 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14722835 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14722835 shares
kays Derivative Liabilities Text Bock
DerivativeLiabilitiesTextBock
<p id="xdx_80B_ecustom--DerivativeLiabilitiesTextBock_zYKWRl5Yus5d" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 <span id="xdx_824_zJV5Eu2db7Eh">DERIVATIVE LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 1, 2019, an equity-linked financial instrument with a down round feature that otherwise is not required to be classified as a liability under the guidance in Topic 480 is evaluated under the guidance in Topic 815, Derivatives and Hedging, to determine whether it meets the definition of a derivative. If it meets that definition, the instrument (or embedded feature) is evaluated to determine whether it is indexed to an entity’s own stock as part of the analysis of whether it qualifies for a scope exception from derivative accounting. Generally, for warrants and conversion options embedded in financial instruments that are deemed to have a debt host (assuming the underlying shares are readily convertible to cash or the contract provides for net settlement such that the embedded conversion option meets the definition of a derivative), the existence of a down round feature results in an instrument not being considered indexed to an entity’s own stock. This results in a reporting entity being required to classify the freestanding financial instrument or the bifurcated conversion option as a liability, which the entity must measure at fair value initially and at each subsequent reporting date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However, due to a recognition of tainting, due to variable conversion price on some of the convertible notes, all convertible notes are considered to have a derivative liability, therefore the Company accounted for these Notes under ASC Topic 815-15 “Embedded Derivative.”  The derivative component of the obligation is initially valued and classified as a derivative liability with an offset to discounts on convertible debt. Discounts are amortized to interest expense over the respective term of the related note. In determining the indicated value of the convertible note issued, the Company used the Binomial Options Pricing Model with a risk-free interest rate of ranging 3.92% to 4.22%, volatility ranging from 152,66% to 170.52%, trading prices ranging from $0.05 per share to $0.11 per share and a conversion price ranging from $0.08 to $0.15 per share. The total derivative liabilities associated with these notes were $8,995,335 at September 30, 2022 and $4,980,563 at December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reset the conversion price of each of the Caymen Ventures notes from $0.15 to $0.08 per share, due to a change in terms.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the application of ASC No. 815, the fair value of the ratchet feature related to convertible debt and warrants is summarized as follow: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zyEjA3BPnWs5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE LIABILITIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B8_zGo90YWzv0Ok" style="display: none">Schedule Of Derivative Liabilities At Fair Value</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: justify">Balance as of December 31, 2021</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20220101__20220930_zqel5OeJUY4e" style="width: 18%; text-align: right" title="Balance at beginning">4,980,563</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Initial</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--InitialDerivativeLiabilities_c20220101__20220930_pp0p0" style="text-align: right" title="Initial">110,134</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Change in Derivative Values</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ChangeInDerivativeLiabilities_c20220101__20220930_pp0p0" style="text-align: right" title="Change in Derivative Liabilities">3,904,638</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Conversion of debt-reclass to APIC</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_ecustom--ConversionOfDebtreclasToApic_c20220101__20220930_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion Of Debtreclas To Apic"><span style="-sec-ix-hidden: xdx2ixbrl1409">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance as of September 30, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20220101__20220930_zmPMRQWW3qs6" style="text-align: right" title="Balance at ending">8,995,335</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AC_zBYxcfNyAmJ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded the debt discount to the extent of the gross proceeds raised and expensed immediately the remaining fair value of the derivative liability, as it exceeded the gross proceeds of the note.  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recoded initial derivative liabilities of $<span id="xdx_909_ecustom--InitialDerivativeLiabilities_c20220101__20220930_pp0p0" title="Initial derivative liabilities">110,134</span> and $<span id="xdx_907_ecustom--InitialDerivativeLiabilities_c20210101__20211231_pp0p0" title="Initial derivative liabilities">882,080</span> for the new notes issued for nine months ended September 30, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded derivative liability expense of $<span id="xdx_904_ecustom--DerivativeLiabilityExpense_c20220101__20220930_pp0p0" title="Derivative liability expense">0</span> and $<span id="xdx_90D_ecustom--DerivativeLiabilityExpense_c20210101__20211231_pp0p0" title="Derivative liability expense">566,080</span> for the nine months ended September 30, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded a change in the value of embedded derivative liabilities expense of $<span id="xdx_908_ecustom--ChangeInValueOfEmbeddedDerivativeLiabilitiesExpense_c20220101__20220930_pp0p0" title="Change in value of embedded derivative liabilities expense">(3,904,639)</span> and a gain of $<span id="xdx_907_ecustom--ChangeInValueOfEmbeddedDerivativeLiabilitiesExpense_c20210101__20211231_pp0p0" title="Change in value of embedded derivative liabilities expense">9,825,029</span> for the three months ended September 30, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
4980563 usd
kays Initial Derivative Liabilities
InitialDerivativeLiabilities
110134 usd
kays Change In Derivative Liabilities
ChangeInDerivativeLiabilities
3904638 usd
CY2022Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
8995335 usd
CY2021 kays Derivative Liability Expense
DerivativeLiabilityExpense
566080 usd
kays Change In Value Of Embedded Derivative Liabilities Expense
ChangeInValueOfEmbeddedDerivativeLiabilitiesExpense
-3904639 usd
CY2021 kays Change In Value Of Embedded Derivative Liabilities Expense
ChangeInValueOfEmbeddedDerivativeLiabilitiesExpense
9825029 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
423950 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
537746 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
163817 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
273184 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
148354 usd
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
332825 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.4744455
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y1M2D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
16667 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
316158 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.4744455
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y7M9D
CY2022Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0932 pure
CY2022Q3 kays Right Of Use Asset
RightOfUseAsset
218789 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
207680 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
89056 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
150182 usd
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Next Rolling Twelve Months
CapitalLeasesFutureMinimumPaymentsNextRollingTwelveMonths
30507 usd
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Due In Rolling Year Two
CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo
109600 usd
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Due In Rolling Year Three
CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree
76617 usd
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Due In Rolling After Year Five
CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive
27041 usd
CY2022Q3 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
243765 usd
CY2022Q3 kays Less Imputed Interest
LessImputedInterest
-24976 usd
CY2022Q3 kays Present Value Of Lease Liabilities
PresentValueOfLeaseLiabilities
218789 usd

Files In Submission

Name View Source Status
0001903596-22-000849-index-headers.html Edgar Link pending
0001903596-22-000849-index.html Edgar Link pending
0001903596-22-000849.txt Edgar Link pending
0001903596-22-000849-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
image_003.jpg Edgar Link pending
image_004.jpg Edgar Link pending
image_005.jpg Edgar Link pending
image_006.jpg Edgar Link pending
image_007.jpg Edgar Link pending
image_008.jpg Edgar Link pending
image_009.jpg Edgar Link pending
image_010.jpg Edgar Link pending
image_011.jpg Edgar Link pending
image_012.jpg Edgar Link pending
image_013.jpg Edgar Link pending
image_014.jpg Edgar Link pending
image_015.jpg Edgar Link pending
image_016.jpg Edgar Link pending
image_017.jpg Edgar Link pending
image_018.jpg Edgar Link pending
image_019.jpg Edgar Link pending
image_020.jpg Edgar Link pending
image_021.jpg Edgar Link pending
image_022.jpg Edgar Link pending
image_023.jpg Edgar Link pending
image_024.jpg Edgar Link pending
image_025.jpg Edgar Link pending
image_026.jpg Edgar Link pending
image_027.jpg Edgar Link pending
image_028.jpg Edgar Link pending
image_029.jpg Edgar Link pending
image_030.jpg Edgar Link pending
image_031.jpg Edgar Link pending
image_032.jpg Edgar Link pending
kays-20220930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kays-20220930_lab.xml Edgar Link unprocessable
kays-20220930_pre.xml Edgar Link unprocessable
kays-20220930_def.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sfskays10q111322.htm Edgar Link pending
sfskays10q111322ex31_1.htm Edgar Link pending
sfskays10q111322ex32_1.htm Edgar Link pending
Show.js Edgar Link pending
kays-20220930_cal.xml Edgar Link unprocessable
sfskays10q111322_htm.xml Edgar Link completed